Percutaneous treatment of a post-TAVI ventricular septal defect: A successful combined procedure for an unusual complication

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 7, 2013, Pages

  Gerckens, Ulrich ^a   Latsios, George ^a   Pizzulli, Luciano ^a  

^a Gemeinschaftskrankenhaus Bonn   (Germany)

Author keywords

complications adult cath intervention; imaging (CT); valvular heart disease

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; BALLOON DILATATION; CARDIOVASCULAR PROCEDURE; CASE REPORT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FUNCTIONAL STATUS; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART VALVE PROSTHESIS; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MALE; POSTOPERATIVE PERIOD; SEPTAL OCCLUDER; SURGICAL WIRE; SYMPTOM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; TRICUSPID VALVE REGURGITATION;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART INJURIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; IATROGENIC DISEASE; MALE; PROSTHESIS DESIGN; SEPTAL OCCLUDER DEVICE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878226916     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24471     Document Type: Article

References (16)

1. Vahanian A, Alfieri OR, Al-Attar N, Antunes MJ, Bax J, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothoracic Surg 2008; 34: 1-8.
2. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624.
3. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703.
4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
5. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
6. Ussia GP, Barbanti M, Imme S, Scarabelli M, Mule M, et al. Management of implant failure during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 76: 440-449.
7. Geisbusch S, Bleiziffer S, Mazzitelli D, Ruge H, Bauernschmitt R, Lange R,. Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation. Circ Cardiovasc Interv 3: 531-536.
8. Gerckens U, Latsios G, Mueller R, Buellesfeld L, John D, Yuecel S, Sauren B, Felderhof T, Iversen S, Grube E,. Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure. JACC Cardiovasc Interv 2010; 3: 244-250.
9. Piazza N, Schultz C, de Jaegere PP, Serruys PW,. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure-Insights into valve-in-valve implantation ("Russian doll concept"). Catheter Cardiovasc Interv 2009; 73: 530-539.
10. Zahn R, Schiele R, Kilkowski C, Klein B, Zeymer U, Werling C, Lehmann A, Gerckens U, Saggau W,. Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValve™ prosthesis due to a too-low implantation, using transcatheter repositioning. J Heart Valve Dis 2011; 20: 64-69.
11. Gerckens U, Latsios G, Mueller R, Buellesfeld L, Sauren B, Iversen S, Felderhof T, Grube E,. Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication. Clin Res Cardiol 2009; 98: 687-690.
12. John D, Buellesfeld L, Yuecel S, Mueller R, Latsios G, Beucher H, Gerckens U, Grube E,. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010; 3: 233-243.
13. Takagi K, Latib A, Al-Lamee R, Mussardo M, Montorfano M, Maisano F, Godino C, Chieffo A, Alfieri O, Colombo A,. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation. Catheter Cardiovasc Interv 2011; 78: 432-443.
14. Wood DA, Tops LF, Mayo JR, Pasupati S, Schalij MJ, et al. Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol 2009; 103: 1295-1301.
15. Messika-Zeitoun D, Serfaty JM, Brochet E, Ducrocq G, Lepage L, et al. Multimodal assessment of the aortic annulus diameter: Implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010; 55: 186-194.
16. Al-Attar N, Ghodbane W, Himbert D, Rau C, Raffoul R, Messika-Zeitoun D, Brochet E, Vahanian A, Nataf P,. Unexpected complications of transapical aortic valve implantation. Ann Thorac Surg 2009; 88: 90-94.